Although HIF1α and HIF2α share many of the same target genes, HIF1α is postulated to act as a tumor suppressor while HIF2α has a pro-oncogenic function in ccRCC [26, 27]. The gene discussed is HIF1A; the disease is nonpapillary renal cell carcinoma.